Pediatric Blood and Marrow Transplantation Program
The Pediatric Blood and Marrow Transplantation Program at the Cancer Center at The Children's Hospital of Philadelphia is one of the oldest pediatric BMT programs in the country. Our program is set apart by the depth of our expertise, the quality of our processes, and our facilities. Our program has been FACT accredited since 2000 for our clinical program, stem cell processing lab, and stem cell collection processes — a recognition of quality care.
Here are some additional distinctions of the Pediatric Blood and Marrow Transplantation Program at CHOP:
- We are one of the few pediatric centers to have a GMP (Good Manufacturing Process) stem cell processing laboratory immunogenetics (tissue typing) laboratory on site.
- We are the only pediatric program in the Delaware Valley accredited by the Foundation for Accreditation of Cellular Therapy, which has rigorous standards of practice for clinical, collection and processing facilities.
- We are the largest pediatric transplant center in PA, NJ, or DE affiliated with the National Marrow Donor Program, which has strict standards for transplantation expertise and procedures.
- We are the only Children's Oncology Group affiliated BMT program in PA, NJ or DE.
Our treatment approach
Our highly experienced pediatric transplant team consists of BMT physicians, radiation oncologists, nurse practitioners, a search coordinator, a social worker, nutritionists and child life specialists — all of whom work together to provide comprehensive care for each patient.
Our dedicated blood and marrow team has extensive expertise in all types of allogeneic hematopoietic stem cell transplants — matched related, partially matched related, unrelated donors, and cord blood. We meet weekly to discuss all referred patients, and we have a dedicated search coordinator for patients who require an unrelated donor or cord blood.
Current areas of research focus for our program include:
- Graft engineering for unrelated donor transplants to minimize graft versus host disease
- Immunotherapy for leukemias
- Reduced intensity conditioning for non-malignant disease transplants
Future areas of research focus will include:
- Immunotherapy to augment graft vs. leukemia
- Improved methods of graft engineering to prevent severe graft versus host disease in unrelated donor transplants
For more information or to make an appointment call 877-ORGAN50 (674-2650).
Visit our Frequently Asked Questions page to learn more about pediatric blood and marrow transplantation at Children's Hospital.
To make an appointment with a Pediatric Blood and Marrow Transplant physician, please call
To arrange a second opinion consultation at the Cancer Center for your child, please call Megan Atkinson at
What Is Leukemia?
Leukemia is a cancer of the bone marrow and blood and is the most common type of childhood cancer. Learn more »
Best in the Nation
CHOP’s Cancer Center was ranked No. 1 by Parents magazine and top ranked by U.S.News & World Report for 2013-14. Learn more »